Skip to main content
. 2022 Jan 29;22(2):70–76. doi: 10.1016/j.ipej.2022.01.004

Table 2.

Comparative evaluation of patients with or without orthostatic hypotension.

Parameters Patients with OH (n = 12) Patients without OH (n = 80) P-value
Age 56.42 ± 11.54 49.78 ± 12.06 0.07
Gender (Male) 7 (58.3%) 47 (58.7%) 0.97
Hypertension 2 (16.6%) 19 (23.7%) 0.58
Symptoms during COVID-19
Fever 11 (91.7%) 52 (65%) 0.06
Cough 9 (75%) 41 (51.2%) 0.124
Sore throat 2 (16.7%) 14 (17.5%) 0.943
Dyspnea 6 (50%) 28 (35%) 0.31
Chest pain 2 (16.6%) 12 (15%) 0.881
Myalgia 3 (25%) 8 (10%) 0.135
Symptoms post COVID-19
Dyspnea
Cough 1 (8.3%) 7 (8.7%) 0.96
Fatigue 4 (33.3%) 7 (8.7%) 0.01
Palpitations 5 (41.7%) 10 (12.5%) 0.01
Orthostatic intolerance 8 (66.7%) 6 (7.5%) <0.0001
Chest pain 2 (16.7%) 12 (15%) 0.88
Dizziness 7 (58.3%) 6 (7.5%) <0.0001
Syncope 2 (16.7%) 0 0.0002
Severity
Asymptomatic 0 12 (15%)
Mild 3 (25%) 35 (43.7%) 0.002
Moderate 4 (33.3%) 28 (35%)
Severe 5 (41.7%) 5 (6.25%)
HRV (RMSSD) [ms] 5.3 ± 3.2 15.2 ± 12.1 0.006
HRV (SDNN) [ms] 9.2 ± 6.0 18.1 ± 13.3 0.02
Mean HR 99.2 ± 17.8 86.4 ± 14.1 0.006
IL-6(pg/ml) 36.3 ± 82.2 6.7 ± 12.4 0.016
CRP(mg/L) 56.4 ± 109.8 15.8 ± 32.4 0.03
D-Dimer(μg/L) 919.9 ± 1283.8 453.2 ± 703.6 0.11
LDH(U/L) 373.4 ± 364.8 364.8 ± 182.3 0.89
Ferritin(μg/L) 8111.7 ± 25513.3 317.2 ± 298.9 0.04
Haemoglobin (gm%) 12.2 ± 2.5 12.4 ± 1.6 0.81
TLC (per mm3) 9283.6 + 2927.7 9138.1 + 9258.8 0.96
LVEF (%) 61.3 ± 5.7 60.5 ± 5.1 0.63
Avg signal value (microV) 0.002 ± 0.006 0.001 ± 0.003 0.26
Avg RR interval (ms) 635.9 ± 127.7 714.6 ± 111.5 0.028

Abbreviations: Avg: average; CRP: C-reactive protein; HR: heart rate; HRV: Heart rate variability; IL-6: interleukin-6; LDH: lactate dehydrogenase; LVEF: left ventricular ejection fraction; ms: millisecond; microV: microvolt; OH: orthostatic hypotension; RMSSD: Root Mean Square Standard Deviation; TLC: total leucocyte count.